Basis: FMP quote market capitalization / four-quarter operating cash flow less absolute capital expenditures. Source: stored company filings and market data; unavailable inputs remain N/A.
The Price/FCF ratio is N/A as of 2026-10-06T15:01:56.630Z.
Calculation as of: 2026-10-06T15:01:56.630Z.
Quote observation: 2026-10-06T14:59:44.000Z. Amounts in USD. The price header may show a later quote.
FMP input reference: 412370d08cb3fb7a3c2e4d636897a8ea9259835d42853a062d33098765049a4f
Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.
PRICE/FCF RATIO
N/A
Market Cap
$380.42M
Price/FCF Ratio
N/A
TTM Avg
25.86
3Y Avg
25.37
5Y Avg
25.37
Market Cap
$384.23M
Price/FCF Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$383.60M
Price/FCF Ratio
N/A
TTM Avg
1258.06
3Y Avg
1258.06
5Y Avg
226.77
Market Cap
$392.03M
Price/FCF Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$356.59M
Price/FCF Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$356.03M
Price/FCF Ratio
N/A
TTM Avg
6.69
3Y Avg
6.69
5Y Avg
6.69
| NAME | MARKET CAP | PRICE/FCF RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Canopy Growth Corporation (CGC) | $373.18M | N/A | N/A | N/A | N/A |
| Arcturus Therapeutics Holdings Inc. (ARCT)vs › | $380.42M | N/A | 25.86 | 25.37 | 25.37 |
| Kyverna Therapeutics, Inc. (KYTX)vs › | $384.23M | N/A | N/A | N/A | N/A |
| Orthofix Medical Inc. (OFIX)vs › | $383.60M | N/A | 1258.06 | 1258.06 | 226.77 |
| MapLight Therapeutics, Inc. (MPLT)vs › | $392.03M | N/A | N/A | N/A | N/A |
| Orchestra BioMed Holdings, Inc. (OBIO)vs › | $356.59M | N/A | N/A | N/A | N/A |
| Ocugen, Inc. (OCGN)vs › | $356.07M | N/A | N/A | N/A | N/A |
| Fennec Pharmaceuticals Inc. (FENC)vs › | $356.03M | N/A | 6.69 | 6.69 | 6.69 |
| Embecta Corp. (EMBC)vs › | $354.48M | 2.15 | 2.83 | 26.37 | 19.21 |
| Opus Genetics, Inc. (IRD)vs › | $354.20M | N/A | N/A | N/A | N/A |
P/FCF Ratio
N/A
FCF Yield
N/A
P/FCF measures market price relative to free cash flow per share. Free cash flow is operating cash flow after capital expenditures.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
